The Board Advisory Council provides guidance, advice, and support to help the AMSA Board of Trustees achieve its strategic objectives. The purpose of the Board Advisory Council is:
To be articulate spokespersons for and ambassadors for AMSA among alumni, friends, associates, and colleagues
To advise, counsel, and support the Board of Trustees to further the mission of AMSA
To assist in the acquisition of resources essential to the further advancement of AMSA in its teaching, research, and service missions.
Lucy Ferrante is the Chief Financial Officer at Cone Communications, a public relations agency in Boston, Massachusetts, focused on Corporate Social Responsibility and Consumer Marketing. In her role, she ensures Cone’s commitment to excellence and superior client service extends to the agency’s financial operations. Drawing upon more than 25 years’ experience she guides Cone’s financial strategy, management and reporting, and liaises with the agency’s parent company, Omnicom. Lucy has a keen ability to turn complicated and complex financial information into material employees at all levels can understand. Previously, Lucy spent over 15 years at Feinstein Kean Healthcare, a public relations agency in Cambridge, Massachusetts, focused on Healthcare and Biotechnology.
Lucy earned her Bachelor of Science degree in Accounting and Finance from the University of Massachusetts Lowell. She currently lives in Marlborough with her husband and two sons, one of which is a student at AMSA.
Patricia Keating is a clinical trial professional with more than 10 years of experience in the medical device industry. Her clinical trial career began as a research coordinator in the ophthalmology department at Tufts Medical Center in Boston. Since then, she has managed various stages of medical device clinical trials both domestically and internationally, mostly with local start-up device companies. In July 2018, she joined Boston Scientific’s Interventional Cardiology division as a Clinical Trial Manager in the TAVR program. She was introduced to AMSA via Boston Scientific’s community engagement programs and is looking forward to providing continued support of this partnership.
Born in Manila, Philippines, she moved to the San Francisco Bay Area at age 12 and completed her undergraduate degree in Molecular and Cell Biology with a concentration in genetics at the University of California, Berkeley in 2006. She then re-located to Boston to pursue a masters in biomedical sciences at Boston University in 2007. She has grown to love New England over the past decade and lives in Hopkinton, MA with her husband, Matt. In addition to working at Boston Scientific, Patricia is currently pursuing an MBA at Babson College and is also a third-year mentor for the Big Brother Big Sister’s Mentor 2.0 program. In her free time, she enjoys running and most fitness-related activities, reading, and finding the latest donut spots in the Boston area.
Pauline Jen Ryan is a Partner with Red Sky Partners, an advisory firm providing strategic counsel and interim management services to biotech companies. Previously, she was CEO of Verik Bio, a cancer immunotherapy company and Senior Vice President of Business Operations, Corporate Secretary & Treasurer at Proteostasis Therapeutics. From 1999-2007, Ms. Ryan held positions of increasing responsibility at ImmunoGen, Inc. culminating as Senior Vice President, Corporate Development & Operations where she oversaw strategic planning, business development, alliance management, human resources and project management as well as manufacturing, supply chain management, and manufacturing collaborations. Earlier in her career, Ms. Ryan worked in business development at Organogenesis and was a management consultant at ZS Associates and The Alexander Group, providing strategic marketing and sales consulting services to global pharmaceutical companies.
She is a life sciences advisor for the Martin Trust Center for Entrepreneurship at MIT and is a Board member of Distinguished Young Women, a national scholarship organization. Previously, she was a Board member at Solmap Pharmaceuticals (acquired by Forma Therapeutics) and on the Business Development Advisory Board of the Biotechnology Industry Organization.
Ms. Ryan has an MBA from the Kellogg School of Management at Northwestern University with concentrations in health care management, marketing, finance and managerial economics. She is the proud mother of two children, an AMSA student and an AMSA alumna.
